Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Clinical trial NCT03436732 · TERMINATED
Trial details
- NCT number
- NCT03436732
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2019-04-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.